4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-062615
Options or other derivatives
- Director acquired 199,500 shares (grant or award)
From the SEC's structured data for this filing
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-062615
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…